Skip to main content

Patient Engagement

By HIMSS TV | 03:12 pm | September 18, 2019
The strength of Infermedica's symptom checker is how it works with organizations' existing software and processes, says Miłosz Wiciński, the company's business development manager.
By HIMSS TV | 01:40 pm | September 18, 2019
Texas Health Resources' Chief Experience Officer Winjie Miao says patient experience can be a constraining lens as health moves outside the hospital into the community.
By HIMSS TV | 04:40 am | September 17, 2019
James Vlahos, contributor to Wired and other magazines, describes how the Dadbot conversational chatbot provides a sort of "digital afterlife."
By HIMSS TV | 09:01 am | September 09, 2019
Risa Stack, general manager at GE Ventures, discusses new trends in consumerism and patient engagement as well as advances in pharmacogenomic therapies.
By HIMSS TV | 06:33 am | September 05, 2019
Technology is no longer a barrier to at-home healthcare, says Susan Dentzer, president and CEO of the Network for Excellence in Health Innovation.
By HIMSS TV | 05:34 am | September 04, 2019
In the first edition of the HIMSS TV Deep Dive series, we look at the crisis of opioid addiction in the United States, and how to treat and prevent overuse and addiction.
By HIMSS TV | 07:55 am | August 29, 2019
Daniel Kivatinos, COO and co-founder of DrChrono, gives a rundown of his company's mobile EHR platform and demonstrates how it works on either a tablet or smartwatch.
By HIMSS TV | 06:46 am | August 28, 2019
Dr. Steve Lockhart, CMO at Sutter Health, discusses social determinants of health, why unequal care is among the "most disappointing elements" of the U.S. healthcare system and how to fix that.
By HIMSS TV | 07:46 am | August 27, 2019
Dr. John Herman, associate chief of the Department of Psychiatry at Massachusetts General Hospital, says properly vetted apps and technologies present an opportunity for the underserved to get needed help.
By HIMSS TV | 09:28 am | August 26, 2019
By asking evocative questions and analyzing facial expressions and voice inflection, AiME (Artificial Intelligence Mental Evaluation) can assess the risk of depression, anxiety and addiction, says Textpert founder and CEO Ray Christian.

Newsletter Signup